The South Korean government will inject 2.7 trillion won annually starting next year to drastically increase National Health Insurance fees for regional and essential medical services, focusing financial support on severe surgeries, emergency care, childbirth, and neonatal intensive care.
In Plain English: The Clinical Takeaway
- Enhanced Reimbursements: High-complexity procedures like cardiovascular operations, cancer surgeries, and neonatal intensive care will receive significantly higher government payouts to sustain critical specialist work.
- Regional Equity: Healthcare facilities in non-capital regions and designated vulnerable areas will benefit from 10% to 5% bonus additions on treatment and consultation fees to combat rural medical deserts.
- Offsetting Adjustments: To fund these structural shifts, the government will lower overcompensated service fees for diagnostic tests, including 702 laboratory procedures and 480 CT and MRI scans.
Restructuring Reimbursements for Regional and Essential Medical Services
The Ministry of Health and Welfare finalized the implementation plan during the 19th Health Insurance Policy Deliberation Committee meeting, executing 2.7 trillion won out of a broader 3.6 trillion won reimbursement overhaul plan announced in June. The policy targets structural financial imbalances that have historically steered medical professionals away from high-risk fields and underserved geographic locations.
To systematically address regional healthcare gaps, the administration is introducing a regional premium system. Starting in March of next year, general hospitals and higher-level medical institutions across six vulnerable capital-region districts—including parts of Gyeonggi Province such as Pocheon, Icheon, Uijeongbu, and Namyangju, alongside western and central Incheon—plus non-capital regions will receive a 10% fee addition across 2,740 surgical and treatment codes. Furthermore, 86 designated depopulation-threatened districts will see a 5% increase applied directly to basic consultation and inpatient fees.
| Medical Sector | Target / Intervention | Financial Scale & Adjustment |
|---|---|---|
| Pediatrics & Maternity | High-risk maternal emergency transfers, neonatal intensive care units | Up to 3.3 million won additional payout per case; 400 billion won annual support |
| Basic Consultation & Inpatient | Clinic and hospital-level checkups, standard wards, and intensive care units | 6% to 7% hikes for clinics and general wards; 10% for ICUs |
Targeting Severe Surgeries and Emergency Care Deficits
Severe and emergency medical fields will command an annual investment of 900 billion won to fortify final-stage treatment capabilities at general hospitals and tertiary centers. The reimbursement rates for 1,670 high-complexity procedures—such as interventions for cardiovascular disease, cancer, and complex fractures—are slated for a 20% upward adjustment.
Emergency medical services are receiving aggressive structural reinforcements to account for off-hour operational strains. Nighttime and holiday emergency surgeries will see their bonus rates climb dramatically from a maximum of 350% to 450%.
Expanding Pediatric and Maternity Support Mechanisms
The pediatric and obstetric sectors are slated for 400 billion won in annual targeted reinforcements. Comprehensive maternal-infant emergency centers accepting high-risk obstetric transfers will secure up to 2.64 million won in added delivery compensation, with an extra 660,000 won regional incentive added for non-capital and vulnerable areas.
Pediatric care thresholds are widening as the consultation fee age limit extends from under 6 years to under 8 years. Severe operations performed on children under 6 will carry a 50% fee addition, while procedures executed within pediatric intensive care units gain a parallel 50% markup. Institutional support for night and holiday pediatric hubs, known as Moonlight Children’s Hospitals, will be reinforced alongside higher emergency management fees for specialized pediatric emergency centers.
Balancing Budgets Through Diagnostic Adjustments
To maintain fiscal neutrality within the national health insurance framework, the ministry is scaling back overcompensated diagnostic reimbursement streams by approximately 2.6 trillion won annually. Reimbursements for 702 laboratory pathology items—such as routine blood tests carrying cost-to-revenue ratios exceeding 150%—alongside 480 computed tomography and magnetic resonance imaging codes, are targeted for reductions.
Administrative processes for outsourced testing are also transforming. The established management fee for outsourced diagnostics will be eliminated entirely. Instead, the government is implementing a direct-payment mechanism that allocates inspection fees separately and directly to both the requesting medical clinic and the external institution performing the actual assay.
References
- Ministry of Health and Welfare, Republic of Korea. Health Insurance Policy Deliberation Committee Regulatory Proceedings.
